{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T17:53:00Z","timestamp":1771869180311,"version":"3.50.1"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2000,11,1]],"date-time":"2000-11-01T00:00:00Z","timestamp":973036800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2000,11,1]],"date-time":"2000-11-01T00:00:00Z","timestamp":973036800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2000,11]]},"DOI":"10.1136\/ard.59.suppl_1.i54","type":"journal-article","created":{"date-parts":[[2002,7,27]],"date-time":"2002-07-27T10:37:59Z","timestamp":1027766279000},"page":"i54-i59","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"S1","title":["Adenoviral transgene delivery provides an approach to identifying important molecular processes in inflammation: evidence for heterogenecity in the requirement for NF\u03baB in tumour necrosis factor production"],"prefix":"10.1016","volume":"59","author":[{"given":"Brian M J","family":"Foxwell","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Bondeson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fionula","family":"Brennan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc","family":"Feldmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1136\/ard.59.suppl_1.i54_bib1","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1002\/art.1780361206","article-title":"Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to TNF\u03b1.","volume":"36","author":"Elliott","year":"1993","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.59.suppl_1.i54_bib2","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/S0140-6736(94)90628-9","article-title":"Randomised double blind comparison of a chimaeric monoclonal antibody to tumour necrosis factor \u03b1 (cA2) versus placebo in rheumatoid arthritis.","volume":"344","author":"Elliott","year":"1994","journal-title":"Lancet"},{"key":"10.1136\/ard.59.suppl_1.i54_bib3","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1093\/rheumatology\/34.4.334","article-title":"The therapeutic effects of an engineered human anti-tumour necrosis factor alpha antibody (CD571) in rheumatoid arthritis.","volume":"34","author":"Rankin","year":"1995","journal-title":"Br J Rheumatol"},{"key":"10.1136\/ard.59.suppl_1.i54_bib4","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1056\/NEJM199707173370301","article-title":"Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein.","volume":"337","author":"Moreland","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1136\/ard.59.suppl_1.i54_bib5","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0065-2776(08)60891-3","article-title":"Anti tumour necrosis factor \u03b1 therapy of rheumatoid arthritis.","volume":"64","author":"Feldmann","year":"1997","journal-title":"Adv Immunol"},{"key":"10.1136\/ard.59.suppl_1.i54_bib6","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1002\/1529-0131(199809)41:9<1552::AID-ART5>3.0.CO;2-W","article-title":"Therpeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor \u03b1 monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis.","volume":"41","author":"Maini","year":"1998","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.59.suppl_1.i54_bib7","doi-asserted-by":"crossref","first-page":"I56","DOI":"10.1136\/ard.58.2008.i56","article-title":"Anti-tumour necrosis factor specific antibody (infliximab) treatment provides insights into the pathophysiology of rheumatoid arthritis.","volume":"58 (suppl 1)","author":"Maini","year":"1999","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.59.suppl_1.i54_bib8","doi-asserted-by":"crossref","first-page":"217","DOI":"10.3109\/08830189809084493","article-title":"Cytokines in autoimmune disorders.","volume":"17","author":"Feldmann","year":"1998","journal-title":"Int Rev Immunol"},{"key":"10.1136\/ard.59.suppl_1.i54_bib9","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1172\/JCI117394","article-title":"Chronic exposure to tumor necrosis factor (TNF) in vitro impairs the activation of T cells through the T cell receptor\/CD3 complex; reversal in vivo by anti-TNF antibodies in patients with rheumatoid arthritis.","volume":"94","author":"Cope","year":"1994","journal-title":"J Clin Invest"},{"key":"10.1136\/ard.59.suppl_1.i54_bib10","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1084\/jem.185.9.1573","article-title":"Chronic tumor necrosis factor alters T cell responses by attenuating T cell receptor signaling.","volume":"185","author":"Cope","year":"1997","journal-title":"J Exp Med"},{"key":"10.1136\/ard.59.suppl_1.i54_bib11","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1084\/jem.171.1.35","article-title":"Kappa B-type enhancers are involved in lipopolysaccharide-mediated transcriptional activation of the tumor necrosis factor alpha gene in primary macrophages.","volume":"171","author":"Shakhov","year":"1990","journal-title":"J Exp Med"},{"key":"10.1136\/ard.59.suppl_1.i54_bib12","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1002\/jlb.63.3.395","article-title":"Effect of proteasome inhibitors on monocytic IkappaB-alpha and -beta depletion, NF-kappaB activation, and cytokine production.","volume":"63","author":"Haas","year":"1998","journal-title":"J Leukoc Biol"},{"key":"10.1136\/ard.59.suppl_1.i54_bib13","doi-asserted-by":"crossref","first-page":"9769","DOI":"10.1073\/pnas.87.24.9769","article-title":"Human tumor necrosis factor alpha gene regulation by virus and lipopolysaccharide.","volume":"87","author":"Goldfeld","year":"1990","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1136\/ard.59.suppl_1.i54_bib14","doi-asserted-by":"crossref","first-page":"30445","DOI":"10.1016\/S0021-9258(18)43833-1","article-title":"The role of NFATp in cyclosporin A-sensitive tumor necrosis factor-alpha gene transcription.","volume":"269","author":"McCaffrey","year":"1994","journal-title":"J Biol Chem"},{"key":"10.1136\/ard.59.suppl_1.i54_bib15","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1128\/MCB.16.2.459","article-title":"Tumor necrosis factor alpha gene regulation in activated T cells involves ATF-2\/Jun and NFATp.","volume":"16","author":"Tsai","year":"1996","journal-title":"Mol Cell Biol"},{"key":"10.1136\/ard.59.suppl_1.i54_bib16","first-page":"71","article-title":"The essential role of the UA-rich sequence in endotoxin-induced cachectin\/TNF synthesis.","volume":"1","author":"Han","year":"1990","journal-title":"Eur Cytokine Netw"},{"key":"10.1136\/ard.59.suppl_1.i54_bib17","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/385729a0","article-title":"A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells.","volume":"385","author":"Black","year":"1997","journal-title":"Nature"},{"key":"10.1136\/ard.59.suppl_1.i54_bib18","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/385733a0","article-title":"Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-alpha [published erratum appears in Nature 1997 17;386:738].","volume":"385","author":"Moss","year":"1997","journal-title":"Nature"},{"key":"10.1136\/ard.59.suppl_1.i54_bib19","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/icb.1993.8","article-title":"Electroporation and DNA-dependent cell death in murine macrophages.","volume":"71","author":"Stacey","year":"1993","journal-title":"Immunol Cell Biol"},{"key":"10.1136\/ard.59.suppl_1.i54_bib20","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1126\/science.275.5304.1320","article-title":"Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5.","volume":"275","author":"Bergelson","year":"1997","journal-title":"Science"},{"key":"10.1136\/ard.59.suppl_1.i54_bib21","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1128\/jvi.69.4.2257-2263.1995","article-title":"Upregulation of integrins alpha v beta 3 and alpha v beta 5 on human monocytes and T lymphocytes facilitates adenovirus-mediated gene delivery.","volume":"69","author":"Huang","year":"1995","journal-title":"J Virol"},{"key":"10.1136\/ard.59.suppl_1.i54_bib22","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1006\/bbrc.1993.2168","article-title":"Efficient adenovirus-mediated gene transfer into human blood monocyte-derived macrophages.","volume":"195","author":"Haddada","year":"1993","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1136\/ard.59.suppl_1.i54_bib23","doi-asserted-by":"crossref","first-page":"8211","DOI":"10.1073\/pnas.95.14.8211","article-title":"Efficient adenoviral infection with I\u03baB\u03b1 reveals that TNF\u03b1 production in rheumatoid arthritis is NF-\u03baB dependent.","volume":"95","author":"Foxwell","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1136\/ard.59.suppl_1.i54_bib24","doi-asserted-by":"crossref","first-page":"5668","DOI":"10.1073\/pnas.96.10.5668","article-title":"Defining therapeutic targets by using adenovirus: blocking NF-kappaB inhibits both inflammatory and destructive mechanisms in rheumatoid synovium but spares anti-inflammatory mediators.","volume":"96","author":"Bondeson","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1136\/ard.59.suppl_1.i54_bib25","doi-asserted-by":"crossref","first-page":"2939","DOI":"10.4049\/jimmunol.162.5.2939","article-title":"Selective regulation of cytokine induction by adenoviral gene transfer of I\u03baB\u03b1 into human macrophages: LPS but not zymosan induced pro-inflammatory cytokines are inhibited, but IL-10 is NF-\u03baB independent.","volume":"162","author":"Bondeson","year":"1999","journal-title":"J Immunol"},{"key":"10.1136\/ard.59.suppl_1.i54_bib26","doi-asserted-by":"crossref","first-page":"33455","DOI":"10.1074\/jbc.274.47.33455","article-title":"CD45-induced tumor necrosis factor alpha production in monocytes is phosphatidylinositol 3-kinase-dependent and nuclear factor-kappaB-independent.","volume":"274","author":"Hayes","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1136\/ard.59.suppl_1.i54_bib27","doi-asserted-by":"crossref","first-page":"16357","DOI":"10.1074\/jbc.271.27.16357","article-title":"Interleukin-10 stimulation of phosphatidylinositol 3-kinase and p70 S6 kinase is required for the proliferative but not the antiinflammatory effects of the cytokine.","volume":"271","author":"Crawley","year":"1996","journal-title":"J Biol Chem"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724498907?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724498907?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ard.59.suppl_1.i54","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,19]],"date-time":"2025-01-19T06:15:58Z","timestamp":1737267358000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496724498907"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,11]]},"references-count":27,"alternative-id":["S0003496724498907"],"URL":"https:\/\/doi.org\/10.1136\/ard.59.suppl_1.i54","relation":{},"ISSN":["0003-4967"],"issn-type":[{"value":"0003-4967","type":"print"}],"subject":[],"published":{"date-parts":[[2000,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adenoviral transgene delivery provides an approach to identifying important molecular processes in inflammation: evidence for heterogenecity in the requirement for NF\u03baB in tumour necrosis factor production","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ard.59.suppl_1.i54","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2000 Annals of the Rheumatic Diseases, Published by Elsevier Inc. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}